Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Glaucoma | 30 | 2012 | 1182 | 2.680 |
Why?
|
Retinal Ganglion Cells | 18 | 2012 | 806 | 2.350 |
Why?
|
Intraocular Pressure | 29 | 2018 | 1288 | 1.690 |
Why?
|
Glaucoma, Open-Angle | 13 | 2019 | 734 | 1.170 |
Why?
|
Calcineurin | 6 | 2012 | 229 | 0.940 |
Why?
|
Rats, Inbred BN | 13 | 2010 | 231 | 0.830 |
Why?
|
Artificial Organs | 4 | 2012 | 149 | 0.830 |
Why?
|
Macular Degeneration | 3 | 2023 | 1001 | 0.710 |
Why?
|
Wet Macular Degeneration | 1 | 2022 | 162 | 0.680 |
Why?
|
Glaucoma Drainage Implants | 5 | 2012 | 106 | 0.630 |
Why?
|
Enzyme Activators | 1 | 2018 | 57 | 0.620 |
Why?
|
Ciliary Body | 5 | 2014 | 166 | 0.610 |
Why?
|
Guanylate Cyclase | 1 | 2018 | 205 | 0.570 |
Why?
|
Caspases | 5 | 2010 | 876 | 0.530 |
Why?
|
Corneal Diseases | 5 | 2012 | 536 | 0.530 |
Why?
|
Cornea | 4 | 2012 | 1326 | 0.530 |
Why?
|
Tacrolimus | 3 | 2005 | 733 | 0.520 |
Why?
|
Optic Nerve | 3 | 2012 | 567 | 0.510 |
Why?
|
Tonometry, Ocular | 4 | 2018 | 235 | 0.490 |
Why?
|
Exfoliation Syndrome | 5 | 2014 | 113 | 0.440 |
Why?
|
Retinal Dystrophies | 2 | 2024 | 64 | 0.440 |
Why?
|
Retina | 8 | 2023 | 2635 | 0.420 |
Why?
|
Interleukin-17 | 2 | 2015 | 908 | 0.410 |
Why?
|
Laser Coagulation | 2 | 2009 | 329 | 0.410 |
Why?
|
Calpain | 2 | 2010 | 145 | 0.410 |
Why?
|
Trabeculectomy | 6 | 2012 | 174 | 0.390 |
Why?
|
Pyrazoles | 2 | 2022 | 1988 | 0.390 |
Why?
|
Cell Count | 5 | 2007 | 1835 | 0.390 |
Why?
|
Dry Eye Syndromes | 1 | 2015 | 385 | 0.370 |
Why?
|
Visual Acuity | 8 | 2023 | 2642 | 0.370 |
Why?
|
Nerve Degeneration | 2 | 2012 | 748 | 0.370 |
Why?
|
Intravitreal Injections | 4 | 2023 | 384 | 0.360 |
Why?
|
Dendrites | 1 | 2012 | 474 | 0.340 |
Why?
|
Interleukin-1beta | 1 | 2015 | 996 | 0.340 |
Why?
|
Piperidines | 1 | 2018 | 1639 | 0.340 |
Why?
|
Visual Fields | 5 | 2023 | 1054 | 0.320 |
Why?
|
Cloprostenol | 1 | 2008 | 21 | 0.320 |
Why?
|
Retinal Degeneration | 1 | 2012 | 412 | 0.310 |
Why?
|
Cutis Laxa | 1 | 2008 | 29 | 0.310 |
Why?
|
Rats | 20 | 2010 | 23679 | 0.310 |
Why?
|
Antihypertensive Agents | 4 | 2019 | 2016 | 0.310 |
Why?
|
Ocular Hypertension | 5 | 2018 | 206 | 0.300 |
Why?
|
Visual Field Tests | 1 | 2010 | 411 | 0.300 |
Why?
|
Vascular Endothelial Growth Factor A | 5 | 2023 | 3480 | 0.300 |
Why?
|
Blotting, Western | 8 | 2010 | 5031 | 0.280 |
Why?
|
Lens, Crystalline | 2 | 2014 | 388 | 0.280 |
Why?
|
Eye Proteins | 1 | 2010 | 633 | 0.270 |
Why?
|
Optic Nerve Injuries | 2 | 2005 | 147 | 0.270 |
Why?
|
Eyelid Diseases | 1 | 2008 | 157 | 0.270 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2010 | 611 | 0.270 |
Why?
|
Pyridines | 1 | 2018 | 2859 | 0.270 |
Why?
|
Optic Nerve Diseases | 3 | 2012 | 342 | 0.260 |
Why?
|
Disease Models, Animal | 7 | 2010 | 18119 | 0.260 |
Why?
|
Amides | 1 | 2008 | 447 | 0.260 |
Why?
|
Enzyme Activation | 6 | 2012 | 3593 | 0.250 |
Why?
|
Anterior Eye Segment | 3 | 2001 | 141 | 0.250 |
Why?
|
Dependovirus | 2 | 2024 | 711 | 0.240 |
Why?
|
Axons | 1 | 2012 | 1673 | 0.240 |
Why?
|
Scleral Diseases | 2 | 2004 | 22 | 0.230 |
Why?
|
Ophthalmic Solutions | 4 | 2018 | 304 | 0.230 |
Why?
|
Immunosuppressive Agents | 4 | 2015 | 4158 | 0.220 |
Why?
|
Apoptosis | 6 | 2010 | 9468 | 0.220 |
Why?
|
Heat-Shock Proteins | 1 | 2007 | 795 | 0.220 |
Why?
|
Vision Disorders | 2 | 2010 | 1084 | 0.220 |
Why?
|
Cataract | 2 | 2014 | 827 | 0.210 |
Why?
|
Astrocytes | 2 | 2010 | 1337 | 0.210 |
Why?
|
Optic Disk Drusen | 1 | 2023 | 38 | 0.210 |
Why?
|
Retinal Vasculitis | 1 | 2023 | 46 | 0.210 |
Why?
|
Amino Acid Oxidoreductases | 3 | 2014 | 149 | 0.200 |
Why?
|
Uveal Diseases | 1 | 2001 | 45 | 0.200 |
Why?
|
Antibodies, Monoclonal | 2 | 2015 | 9160 | 0.190 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 2 | 2022 | 666 | 0.190 |
Why?
|
Mice, Inbred DBA | 3 | 2007 | 622 | 0.190 |
Why?
|
Caspase 9 | 4 | 2005 | 185 | 0.190 |
Why?
|
Antigen-Antibody Complex | 1 | 2023 | 513 | 0.190 |
Why?
|
Immunophilins | 1 | 2000 | 20 | 0.180 |
Why?
|
Immunohistochemistry | 7 | 2012 | 11070 | 0.170 |
Why?
|
Retinitis Pigmentosa | 1 | 2023 | 397 | 0.170 |
Why?
|
Filtering Surgery | 1 | 2000 | 33 | 0.170 |
Why?
|
Neuroprotective Agents | 3 | 2002 | 955 | 0.170 |
Why?
|
Pharmacokinetics | 1 | 2020 | 86 | 0.170 |
Why?
|
Fructose | 1 | 2001 | 287 | 0.170 |
Why?
|
Glaucoma, Angle-Closure | 1 | 2001 | 191 | 0.160 |
Why?
|
Aqueous Humor | 3 | 2010 | 153 | 0.160 |
Why?
|
No-Observed-Adverse-Effect Level | 1 | 2018 | 25 | 0.160 |
Why?
|
Animals | 33 | 2023 | 167768 | 0.160 |
Why?
|
Eye | 2 | 2020 | 710 | 0.150 |
Why?
|
Fluorescent Antibody Technique, Indirect | 3 | 2014 | 426 | 0.150 |
Why?
|
Angiogenesis Inhibitors | 3 | 2023 | 2047 | 0.150 |
Why?
|
Endothelial Growth Factors | 1 | 1999 | 672 | 0.140 |
Why?
|
Immunoenzyme Techniques | 2 | 2010 | 1705 | 0.140 |
Why?
|
Calcium Channel Blockers | 2 | 2019 | 694 | 0.140 |
Why?
|
Injections, Intravenous | 2 | 2015 | 1378 | 0.130 |
Why?
|
Lymphokines | 1 | 1999 | 926 | 0.130 |
Why?
|
Adipose Tissue | 1 | 2008 | 3299 | 0.130 |
Why?
|
Double-Blind Method | 6 | 2018 | 12262 | 0.130 |
Why?
|
Regional Blood Flow | 2 | 2011 | 1486 | 0.130 |
Why?
|
Lidocaine | 1 | 1999 | 537 | 0.130 |
Why?
|
Postoperative Complications | 6 | 2012 | 15637 | 0.130 |
Why?
|
Maximum Tolerated Dose | 1 | 2018 | 876 | 0.130 |
Why?
|
Male | 38 | 2024 | 358747 | 0.130 |
Why?
|
Disease Progression | 4 | 2019 | 13468 | 0.120 |
Why?
|
Neoplasm Proteins | 1 | 2007 | 3609 | 0.120 |
Why?
|
Gene Expression Regulation | 2 | 2010 | 11892 | 0.120 |
Why?
|
Quinoxalines | 2 | 2011 | 297 | 0.120 |
Why?
|
RNA, Messenger | 3 | 2006 | 12759 | 0.120 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2010 | 4567 | 0.120 |
Why?
|
Blood-Aqueous Barrier | 1 | 2014 | 7 | 0.120 |
Why?
|
Tears | 1 | 2015 | 251 | 0.110 |
Why?
|
Indoles | 1 | 2022 | 1828 | 0.110 |
Why?
|
Nerve Crush | 2 | 2005 | 76 | 0.110 |
Why?
|
Dendritic Spines | 2 | 2012 | 243 | 0.110 |
Why?
|
Muscle, Smooth, Vascular | 1 | 1999 | 1486 | 0.110 |
Why?
|
Elastin | 2 | 2014 | 300 | 0.110 |
Why?
|
Molecular Imaging | 1 | 2020 | 815 | 0.100 |
Why?
|
Humans | 50 | 2024 | 758406 | 0.100 |
Why?
|
Pregnancy Complications | 1 | 2006 | 2942 | 0.100 |
Why?
|
Transcription, Genetic | 1 | 2005 | 7590 | 0.100 |
Why?
|
Anticonvulsants | 1 | 2001 | 1881 | 0.100 |
Why?
|
Eye Burns | 1 | 2011 | 65 | 0.100 |
Why?
|
Eye Infections, Viral | 1 | 1992 | 60 | 0.090 |
Why?
|
Glutamic Acid | 1 | 1997 | 1167 | 0.090 |
Why?
|
Uveitis | 1 | 2015 | 393 | 0.090 |
Why?
|
Surgical Flaps | 1 | 2000 | 1669 | 0.090 |
Why?
|
Burns, Chemical | 1 | 2011 | 122 | 0.090 |
Why?
|
Conjunctivitis | 1 | 1992 | 155 | 0.090 |
Why?
|
Stilbamidines | 1 | 2010 | 43 | 0.090 |
Why?
|
Retinal Detachment | 2 | 2006 | 427 | 0.090 |
Why?
|
Ethmoid Sinus | 1 | 2010 | 57 | 0.090 |
Why?
|
Green Fluorescent Proteins | 2 | 2012 | 2057 | 0.090 |
Why?
|
Transduction, Genetic | 1 | 2012 | 896 | 0.080 |
Why?
|
Aged | 18 | 2023 | 168218 | 0.080 |
Why?
|
Female | 26 | 2024 | 390323 | 0.080 |
Why?
|
Pyrimidines | 1 | 2022 | 3006 | 0.080 |
Why?
|
Ultraviolet Rays | 1 | 2014 | 1076 | 0.080 |
Why?
|
Laser Therapy | 3 | 2005 | 1089 | 0.080 |
Why?
|
Spectrin | 1 | 2010 | 170 | 0.080 |
Why?
|
Cytoprotection | 1 | 2010 | 199 | 0.080 |
Why?
|
Heart Rate | 3 | 2012 | 4166 | 0.080 |
Why?
|
Genetic Vectors | 2 | 2024 | 3380 | 0.080 |
Why?
|
Transgenes | 1 | 2012 | 1007 | 0.080 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2014 | 1171 | 0.080 |
Why?
|
Lasers, Semiconductor | 1 | 2009 | 41 | 0.080 |
Why?
|
Eye Infections, Bacterial | 1 | 1992 | 239 | 0.080 |
Why?
|
Blood Pressure | 6 | 2012 | 8451 | 0.080 |
Why?
|
Middle Aged | 16 | 2024 | 219568 | 0.080 |
Why?
|
Enophthalmos | 1 | 2008 | 34 | 0.080 |
Why?
|
Maxillary Sinus | 1 | 2010 | 180 | 0.080 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2010 | 507 | 0.080 |
Why?
|
Polymorphism, Single Nucleotide | 4 | 2012 | 15773 | 0.070 |
Why?
|
Treatment Outcome | 5 | 2024 | 64378 | 0.070 |
Why?
|
Endophthalmitis | 2 | 2010 | 257 | 0.070 |
Why?
|
Cell Death | 2 | 2007 | 1668 | 0.070 |
Why?
|
Lacrimal Apparatus | 1 | 2010 | 223 | 0.070 |
Why?
|
Coffee | 1 | 2012 | 582 | 0.070 |
Why?
|
Administration, Topical | 2 | 2008 | 697 | 0.070 |
Why?
|
Amyloid beta-Peptides | 2 | 2012 | 3826 | 0.070 |
Why?
|
Caffeine | 1 | 2012 | 701 | 0.070 |
Why?
|
HSP27 Heat-Shock Proteins | 1 | 2007 | 66 | 0.070 |
Why?
|
Immunoprecipitation | 1 | 2010 | 877 | 0.070 |
Why?
|
Adult | 13 | 2024 | 219935 | 0.070 |
Why?
|
Glucocorticoids | 2 | 2015 | 2144 | 0.070 |
Why?
|
Mice | 9 | 2023 | 81101 | 0.070 |
Why?
|
Corticotropin-Releasing Hormone | 1 | 1988 | 361 | 0.070 |
Why?
|
Poly(ADP-ribose) Polymerases | 2 | 2005 | 425 | 0.070 |
Why?
|
Adolescent | 6 | 2024 | 87892 | 0.070 |
Why?
|
Young Adult | 5 | 2024 | 58808 | 0.070 |
Why?
|
Eye Enucleation | 1 | 2006 | 128 | 0.070 |
Why?
|
Anterior Chamber | 2 | 2014 | 194 | 0.070 |
Why?
|
Immunoblotting | 2 | 2014 | 1647 | 0.060 |
Why?
|
Depression, Chemical | 1 | 2005 | 184 | 0.060 |
Why?
|
Homocysteine | 1 | 2008 | 638 | 0.060 |
Why?
|
Cell Survival | 2 | 2010 | 5781 | 0.060 |
Why?
|
Cerebral Ventricles | 1 | 1988 | 542 | 0.060 |
Why?
|
Mice, Transgenic | 3 | 2012 | 9518 | 0.060 |
Why?
|
bcl-Associated Death Protein | 1 | 2005 | 102 | 0.060 |
Why?
|
Eye Infections | 2 | 2010 | 62 | 0.060 |
Why?
|
Neurites | 3 | 2010 | 390 | 0.060 |
Why?
|
DNA Primers | 2 | 2000 | 2816 | 0.060 |
Why?
|
Phosphorylation | 2 | 2007 | 8297 | 0.060 |
Why?
|
Photoreceptor Cells, Vertebrate | 2 | 2006 | 203 | 0.060 |
Why?
|
Conjunctiva | 1 | 2009 | 479 | 0.060 |
Why?
|
Caspase 8 | 1 | 2005 | 189 | 0.060 |
Why?
|
Cytochromes c | 1 | 2005 | 173 | 0.060 |
Why?
|
In Situ Nick-End Labeling | 2 | 2003 | 609 | 0.060 |
Why?
|
Prostheses and Implants | 1 | 2011 | 1270 | 0.060 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2010 | 1134 | 0.060 |
Why?
|
Trabecular Meshwork | 1 | 2005 | 100 | 0.060 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2006 | 590 | 0.060 |
Why?
|
Chemokine CCL2 | 1 | 2006 | 604 | 0.060 |
Why?
|
Vitreous Body | 2 | 2015 | 399 | 0.060 |
Why?
|
Blister | 1 | 2004 | 86 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2022 | 9273 | 0.060 |
Why?
|
Central Nervous System Stimulants | 1 | 2012 | 1176 | 0.060 |
Why?
|
Calibration | 1 | 2006 | 814 | 0.050 |
Why?
|
Atrophy | 1 | 2008 | 1627 | 0.050 |
Why?
|
Complement Factor B | 1 | 2023 | 72 | 0.050 |
Why?
|
Cell Nucleus | 1 | 2012 | 2907 | 0.050 |
Why?
|
Nimodipine | 2 | 1999 | 56 | 0.050 |
Why?
|
Enzyme Precursors | 1 | 2002 | 174 | 0.050 |
Why?
|
Interleukin-1 | 1 | 2006 | 1249 | 0.050 |
Why?
|
Aged, 80 and over | 6 | 2015 | 58683 | 0.050 |
Why?
|
Dizocilpine Maleate | 2 | 1999 | 172 | 0.050 |
Why?
|
Hyphema | 1 | 2002 | 26 | 0.050 |
Why?
|
Follow-Up Studies | 5 | 2011 | 39059 | 0.050 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2010 | 3774 | 0.050 |
Why?
|
Calcinosis | 1 | 2010 | 1467 | 0.050 |
Why?
|
Exudates and Transudates | 1 | 2001 | 174 | 0.050 |
Why?
|
Macaca fascicularis | 1 | 2023 | 900 | 0.050 |
Why?
|
Tissue Distribution | 2 | 2020 | 2262 | 0.040 |
Why?
|
Adrenergic alpha-Agonists | 1 | 2001 | 177 | 0.040 |
Why?
|
Clonidine | 1 | 2001 | 169 | 0.040 |
Why?
|
Antibodies | 1 | 2008 | 2420 | 0.040 |
Why?
|
Subcellular Fractions | 2 | 2012 | 532 | 0.040 |
Why?
|
Ophthalmologic Surgical Procedures | 2 | 2002 | 353 | 0.040 |
Why?
|
Ophthalmia, Sympathetic | 1 | 2000 | 18 | 0.040 |
Why?
|
RNA | 1 | 2010 | 2716 | 0.040 |
Why?
|
Environmental Exposure | 1 | 2014 | 4412 | 0.040 |
Why?
|
Retinal Pigment Epithelium | 1 | 2023 | 301 | 0.040 |
Why?
|
Culture Media, Conditioned | 2 | 2012 | 522 | 0.040 |
Why?
|
omega-Conotoxins | 1 | 1999 | 18 | 0.040 |
Why?
|
Calcium Channels, N-Type | 1 | 1999 | 43 | 0.040 |
Why?
|
Tacrolimus Binding Proteins | 1 | 2000 | 193 | 0.040 |
Why?
|
NFATC Transcription Factors | 2 | 2012 | 381 | 0.040 |
Why?
|
Retrospective Studies | 7 | 2012 | 80168 | 0.040 |
Why?
|
Eye Injuries | 1 | 2002 | 227 | 0.040 |
Why?
|
Reproducibility of Results | 2 | 2007 | 20055 | 0.040 |
Why?
|
Down-Regulation | 1 | 2006 | 2904 | 0.040 |
Why?
|
Cataract Extraction | 1 | 2003 | 465 | 0.040 |
Why?
|
Optic Neuritis | 1 | 2001 | 174 | 0.040 |
Why?
|
Receptors, Growth Factor | 1 | 1999 | 326 | 0.040 |
Why?
|
Cysts | 1 | 2004 | 681 | 0.040 |
Why?
|
Rats, Long-Evans | 1 | 1999 | 378 | 0.040 |
Why?
|
Staining and Labeling | 1 | 2002 | 1083 | 0.040 |
Why?
|
Excitatory Amino Acid Antagonists | 2 | 1999 | 448 | 0.040 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 1999 | 747 | 0.040 |
Why?
|
Equipment Design | 1 | 2006 | 3507 | 0.040 |
Why?
|
Iris | 2 | 2014 | 231 | 0.040 |
Why?
|
Adjuvants, Immunologic | 1 | 2023 | 1038 | 0.040 |
Why?
|
Primates | 1 | 2020 | 523 | 0.040 |
Why?
|
Nitroglycerin | 1 | 1998 | 328 | 0.040 |
Why?
|
Analysis of Variance | 1 | 2005 | 6234 | 0.030 |
Why?
|
Time Factors | 5 | 2007 | 39872 | 0.030 |
Why?
|
Mendelian Randomization Analysis | 1 | 2022 | 993 | 0.030 |
Why?
|
Necrosis | 1 | 2001 | 1604 | 0.030 |
Why?
|
Up-Regulation | 1 | 2005 | 4113 | 0.030 |
Why?
|
Rats, Wistar | 1 | 2000 | 1844 | 0.030 |
Why?
|
Proteomics | 1 | 2010 | 3816 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 1999 | 557 | 0.030 |
Why?
|
Memantine | 1 | 1997 | 106 | 0.030 |
Why?
|
Sympathetic Nervous System | 2 | 1989 | 518 | 0.030 |
Why?
|
Rats, Inbred Strains | 4 | 1991 | 2090 | 0.030 |
Why?
|
Protein Transport | 2 | 2012 | 1963 | 0.030 |
Why?
|
Calcium Channels | 1 | 1999 | 618 | 0.030 |
Why?
|
Delayed-Action Preparations | 1 | 2018 | 961 | 0.030 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2006 | 4342 | 0.030 |
Why?
|
Verapamil | 1 | 1995 | 242 | 0.030 |
Why?
|
Ultrasonography, Doppler, Color | 1 | 1995 | 231 | 0.030 |
Why?
|
Gene Expression Profiling | 1 | 2010 | 9404 | 0.030 |
Why?
|
Microscopy, Immunoelectron | 1 | 2014 | 317 | 0.030 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 1999 | 892 | 0.030 |
Why?
|
Cattle | 1 | 1999 | 3845 | 0.030 |
Why?
|
Base Sequence | 2 | 2008 | 12436 | 0.030 |
Why?
|
Fluorescein | 1 | 2014 | 174 | 0.030 |
Why?
|
Injections, Subcutaneous | 1 | 2015 | 677 | 0.030 |
Why?
|
Inflammation | 2 | 2023 | 10718 | 0.030 |
Why?
|
Leisure Activities | 1 | 2014 | 306 | 0.030 |
Why?
|
Sunlight | 1 | 2014 | 337 | 0.030 |
Why?
|
Hemodynamics | 2 | 2011 | 4159 | 0.030 |
Why?
|
Risk Factors | 5 | 2022 | 73809 | 0.030 |
Why?
|
Mice, Inbred C57BL | 2 | 2014 | 22003 | 0.030 |
Why?
|
Genetic Loci | 1 | 2022 | 2612 | 0.030 |
Why?
|
Genetic Variation | 1 | 2008 | 6548 | 0.030 |
Why?
|
Silver Nitrate | 1 | 1992 | 13 | 0.030 |
Why?
|
Israel | 1 | 2014 | 721 | 0.030 |
Why?
|
Neovascularization, Physiologic | 1 | 1999 | 1332 | 0.030 |
Why?
|
Occupations | 1 | 2014 | 515 | 0.030 |
Why?
|
Gene Frequency | 2 | 2010 | 3612 | 0.030 |
Why?
|
Mitochondria | 1 | 2005 | 3584 | 0.030 |
Why?
|
Gonioscopy | 1 | 2012 | 155 | 0.020 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 1999 | 1613 | 0.020 |
Why?
|
Sexually Transmitted Diseases, Viral | 1 | 1992 | 40 | 0.020 |
Why?
|
Polymerase Chain Reaction | 2 | 2014 | 6068 | 0.020 |
Why?
|
Sexually Transmitted Diseases, Bacterial | 1 | 1992 | 30 | 0.020 |
Why?
|
Chromatography, Gel | 1 | 2012 | 645 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2024 | 4938 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2010 | 3801 | 0.020 |
Why?
|
Laser-Doppler Flowmetry | 1 | 2011 | 239 | 0.020 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 2012 | 534 | 0.020 |
Why?
|
Sinus of Valsalva | 1 | 1991 | 60 | 0.020 |
Why?
|
Retinal Artery | 1 | 2011 | 109 | 0.020 |
Why?
|
Medulla Oblongata | 2 | 1989 | 248 | 0.020 |
Why?
|
Receptors, AMPA | 1 | 2012 | 322 | 0.020 |
Why?
|
Neurons | 1 | 2010 | 9416 | 0.020 |
Why?
|
Postmortem Changes | 1 | 2010 | 119 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2010 | 18940 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 1999 | 6520 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2006 | 15225 | 0.020 |
Why?
|
Fluorescence Resonance Energy Transfer | 1 | 2012 | 418 | 0.020 |
Why?
|
Eye Diseases | 1 | 2015 | 651 | 0.020 |
Why?
|
Alleles | 2 | 2012 | 6895 | 0.020 |
Why?
|
DNA, Complementary | 1 | 2012 | 1991 | 0.020 |
Why?
|
Fluorescein Angiography | 1 | 2014 | 1044 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2019 | 6493 | 0.020 |
Why?
|
Optic Disk | 1 | 2012 | 421 | 0.020 |
Why?
|
Ultrasonography | 1 | 2001 | 5952 | 0.020 |
Why?
|
Injections, Intraventricular | 1 | 1988 | 225 | 0.020 |
Why?
|
Cytoplasm | 1 | 2012 | 1514 | 0.020 |
Why?
|
Blood Flow Velocity | 1 | 2011 | 1370 | 0.020 |
Why?
|
Cell Movement | 1 | 1999 | 5201 | 0.020 |
Why?
|
Endothelium, Vascular | 1 | 1999 | 4429 | 0.020 |
Why?
|
Algorithms | 1 | 2007 | 13961 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 1999 | 4485 | 0.020 |
Why?
|
Antidepressive Agents | 1 | 2019 | 2889 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2008 | 17768 | 0.020 |
Why?
|
Genotype | 2 | 2012 | 12945 | 0.020 |
Why?
|
Posture | 1 | 2011 | 953 | 0.020 |
Why?
|
Plasmids | 1 | 2012 | 2275 | 0.020 |
Why?
|
Beverages | 1 | 2012 | 819 | 0.020 |
Why?
|
Hypoglycemic Agents | 1 | 2019 | 3069 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2012 | 2048 | 0.020 |
Why?
|
Fluorescent Dyes | 1 | 2014 | 1897 | 0.020 |
Why?
|
Prospective Studies | 3 | 2023 | 54137 | 0.020 |
Why?
|
Alzheimer Disease | 2 | 2012 | 8544 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2011 | 2850 | 0.020 |
Why?
|
Phenotype | 2 | 2014 | 16534 | 0.020 |
Why?
|
Blood Vessels | 1 | 1991 | 1112 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2008 | 20500 | 0.020 |
Why?
|
Residence Characteristics | 1 | 2014 | 2058 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2012 | 2646 | 0.020 |
Why?
|
Microtubule-Associated Proteins | 1 | 2010 | 1074 | 0.010 |
Why?
|
Actins | 1 | 2012 | 2049 | 0.010 |
Why?
|
Prosthesis-Related Infections | 1 | 2010 | 486 | 0.010 |
Why?
|
Pregnancy | 1 | 2006 | 29742 | 0.010 |
Why?
|
Amyloid beta-Protein Precursor | 1 | 2010 | 1110 | 0.010 |
Why?
|
Oligopeptides | 1 | 2010 | 1185 | 0.010 |
Why?
|
Mutation | 2 | 2024 | 29915 | 0.010 |
Why?
|
Embryo, Mammalian | 1 | 2010 | 1674 | 0.010 |
Why?
|
Case-Control Studies | 2 | 2014 | 22029 | 0.010 |
Why?
|
United States | 3 | 2019 | 72136 | 0.010 |
Why?
|
Antimetabolites | 1 | 2004 | 128 | 0.010 |
Why?
|
Caspase 7 | 1 | 2003 | 49 | 0.010 |
Why?
|
Organ Specificity | 1 | 1988 | 1955 | 0.010 |
Why?
|
Diagnosis, Differential | 2 | 2000 | 12951 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2022 | 12604 | 0.010 |
Why?
|
Linkage Disequilibrium | 1 | 2008 | 1996 | 0.010 |
Why?
|
Microscopy, Confocal | 1 | 2009 | 1969 | 0.010 |
Why?
|
Synapses | 1 | 2012 | 1757 | 0.010 |
Why?
|
Aging | 1 | 2001 | 8650 | 0.010 |
Why?
|
Haplotypes | 1 | 2008 | 2764 | 0.010 |
Why?
|
Medicare | 1 | 2019 | 6741 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2008 | 36284 | 0.010 |
Why?
|
Caspase 3 | 1 | 2003 | 728 | 0.010 |
Why?
|
Neuroglia | 1 | 2006 | 944 | 0.010 |
Why?
|
Chronic Disease | 1 | 2015 | 9267 | 0.010 |
Why?
|
omega-Agatoxin IVA | 1 | 1999 | 18 | 0.010 |
Why?
|
omega-Conotoxin GVIA | 1 | 1999 | 19 | 0.010 |
Why?
|
2-Amino-5-phosphonovalerate | 1 | 1999 | 58 | 0.010 |
Why?
|
6-Cyano-7-nitroquinoxaline-2,3-dione | 1 | 1999 | 55 | 0.010 |
Why?
|
Blood | 1 | 2002 | 586 | 0.010 |
Why?
|
Spider Venoms | 1 | 1999 | 43 | 0.010 |
Why?
|
Treatment Failure | 1 | 2005 | 2640 | 0.010 |
Why?
|
Incidence | 2 | 2011 | 21272 | 0.010 |
Why?
|
Cell Line | 1 | 2012 | 15591 | 0.010 |
Why?
|
Risk Assessment | 1 | 2019 | 23884 | 0.010 |
Why?
|
Wound Healing | 1 | 2009 | 2783 | 0.010 |
Why?
|
Calcium Channels, L-Type | 1 | 1999 | 240 | 0.010 |
Why?
|
Peptide Fragments | 1 | 2010 | 5098 | 0.010 |
Why?
|
Cell Size | 1 | 1999 | 623 | 0.010 |
Why?
|
Mice, Inbred Strains | 1 | 1999 | 1759 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2008 | 4711 | 0.010 |
Why?
|
Calcium | 1 | 2010 | 5721 | 0.010 |
Why?
|
Safety | 1 | 2001 | 1147 | 0.010 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 1986 | 3759 | 0.010 |
Why?
|
Membrane Potentials | 1 | 1999 | 1094 | 0.010 |
Why?
|
Cell Polarity | 1 | 1999 | 638 | 0.010 |
Why?
|
Massachusetts | 1 | 2008 | 8823 | 0.010 |
Why?
|
Child | 1 | 2003 | 79818 | 0.010 |
Why?
|
Reoperation | 1 | 2005 | 4282 | 0.010 |
Why?
|
Blood Circulation | 1 | 1995 | 249 | 0.010 |
Why?
|
Heart Ventricles | 1 | 1986 | 3806 | 0.010 |
Why?
|
Cerebral Cortex | 1 | 2010 | 5759 | 0.010 |
Why?
|
Kidney | 1 | 1989 | 7016 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 1992 | 7403 | 0.010 |
Why?
|
Nerve Block | 2 | 1991 | 688 | 0.010 |
Why?
|
Infant, Newborn | 1 | 1992 | 26183 | 0.010 |
Why?
|
Arginine Vasopressin | 1 | 1991 | 125 | 0.010 |
Why?
|
History, 20th Century | 1 | 1999 | 2772 | 0.010 |
Why?
|
Phenylephrine | 1 | 1991 | 293 | 0.010 |
Why?
|
Arteries | 1 | 1995 | 1125 | 0.010 |
Why?
|
Prognosis | 2 | 2002 | 29557 | 0.010 |
Why?
|
Denervation | 1 | 1991 | 263 | 0.010 |
Why?
|
Afferent Pathways | 1 | 1991 | 298 | 0.010 |
Why?
|
Recurrence | 1 | 2002 | 8426 | 0.010 |
Why?
|
Retinal Vessels | 1 | 1995 | 836 | 0.010 |
Why?
|
Hypertension | 1 | 1989 | 8499 | 0.000 |
Why?
|
Vascular Resistance | 1 | 1991 | 930 | 0.000 |
Why?
|
Vasoconstrictor Agents | 1 | 1991 | 651 | 0.000 |
Why?
|
Peptides | 1 | 1999 | 4341 | 0.000 |
Why?
|
Cats | 1 | 1986 | 976 | 0.000 |
Why?
|
Mice, Knockout | 1 | 1999 | 14354 | 0.000 |
Why?
|
Comorbidity | 1 | 1998 | 10495 | 0.000 |
Why?
|
Models, Anatomic | 1 | 1986 | 681 | 0.000 |
Why?
|
Dogs | 1 | 1986 | 3840 | 0.000 |
Why?
|
Organ Size | 1 | 1986 | 2252 | 0.000 |
Why?
|